Results

Total Results: 10 records

Showing results for "anticoagulant prophylaxis".

  1. digital.ahrq.gov/technology/fast-healthcare-interoperability-resources-fhir
    August 01, 2024 - , hybrid type II trial of interoperable clinical decision support to improve venous thromboembolism prophylaxis … , hybrid type II trial of interoperable clinical decision support to improve venous thromboembolism prophylaxis … Ozaydin, Bunyamin Implementation of DDInteract: A Shared Decision Making Tool for Anticoagulant … DDInteract, a shared decision making clinical decision support tool that aims to reduce harm from oral anticoagulant
  2. digital.ahrq.gov/medical-condition/thromboembolism
    January 01, 2024 - , hybrid type II trial of interoperable clinical decision support to improve venous thromboembolism prophylaxis … , hybrid type II trial of interoperable clinical decision support to improve venous thromboembolism prophylaxis … Support System Implementation of DDInteract: A Shared Decision Making Tool for Anticoagulant … Ronilda Drug-drug interaction between dexamethasone and direct-acting oral anticoagulants … Drug-drug interaction between dexamethasone and direct-acting oral anticoagulants: A nested case-control
  3. digital.ahrq.gov/health-it-tools-and-resources/health-it-costs-and-benefits-database/clinical-decision-support-system
    June 07, 2000 - Purpose of Study:  Determine whether presentation of venous thromboembolism prophylaxis guidelines using
  4. digital.ahrq.gov/ahrq-funded-projects/evaluation-scaled-scaling-acceptable-cds-approach-implementation-interoperable-cds-venous
    January 01, 2024 - researchers plan to scale and evaluate the implementation of a CDS tool for venous thromboembolism (VTE) prophylaxis … The researchers plan to widely disseminate this new VTE prophylaxis in TBI tool with U.S. trauma societies … , hybrid type II trial of interoperable clinical decision support to improve venous thromboembolism prophylaxis … , hybrid type II trial of interoperable clinical decision support to improve venous thromboembolism prophylaxis … The researchers plan to widely disseminate this new VTE prophylaxis CDS tool for TBI patients to U.S.
  5. digital.ahrq.gov/sites/default/files/docs/transforming-guidelines-action-slides-06152023.pdf
    June 15, 2023 - Proportion of admitted patients with pharmacologic VTE prophylaxis Proctor’s E et al Adm Policy … Order Set Open the VTE Prophylaxis (Medical) order set. 45 IMPROVE-DD VTE CDS … Workflow #1: VTE Prophylaxis Order Set (Cont’d) Click the checkbox to launch the IMPROVE-DD … An Ideal RAM for DVT Prophylaxis in Medical Inpatients External Validation of VTE RAMs in Medically … Order Set IMPROVE-DD VTE CDS Workflow #1: VTE Prophylaxis Order Set (Cont’d) IMPROVE-DD VTE CDS
  6. digital.ahrq.gov/sites/default/files/docs/page/reduction-in-hospital-acquired-complications-and-infections-quick-reference-guide.pdf
    January 01, 2010 - can be prevented by following recommendations of the American College of Chest Physicians for use of anticoagulants … Use of antimicrobial prophylaxis for major surgery: baseline results from the National Surgical Infection
  7. digital.ahrq.gov/sites/default/files/docs/citation/r21hs021322-sarkar-final-report-2015.pdf
    January 01, 2015 - Over 20 million Americans take warfarin, an anticoagulant, in the ambulatory setting to protect against … thrombosis Mitral/aortic valve replacement Hypercoagulation Pulmonary arterial hypertension Orthopedic prophylaxis … A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy.
  8. digital.ahrq.gov/sites/default/files/docs/medication-management-elderly-slides-081811.pdf
    August 18, 2011 - 100 120 Drug interactions Inadequate monitoring Failure to act on monitoring Known allergy No prophylaxis
  9. digital.ahrq.gov/sites/default/files/docs/publication/r18hs017010-bailey-final-report-2011.pdf
    January 01, 2011 - previous work we have shown that ambulatory ADEs related to high-alert medications – particularly anticoagulants … started during hospitalization may be continued without adequate outpatient monitoring (e.g., oral anticoagulants … definition: “an effect which is noxious and unintended, and which occurs at doses used in man for prophylaxis … hazardous medications that are used heavily in adults, but much less frequently in children – such as anticoagulants
  10. digital.ahrq.gov/sites/default/files/docs/citation/r01hs026732-usher-final-report-2023.pdf
    January 01, 2023 - ; 95% CI, 0.66-0.99) and the use of COVID-19–specific therapeutics including deep vein thrombosis prophylaxis

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: